Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated 2024-05-16 2024-04-29
Drug Identification Number 02227029 02227029
Brand name AMPICILLIN FOR INJECTION, USP AMPICILLIN FOR INJECTION, USP
Common or Proper name AMPICILLIN FOR INJECTION, USP AMPICILLIN FOR INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients AMPICILLIN AMPICILLIN
Strength(s) 250MG 250MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 10 mL 10 mL
ATC code J01CA J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2024-04-23 2024-04-23
Estimated end date 2024-05-07 2024-05-07
Actual end date 2024-05-15
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Ampicillin for Injection 250 mg SD Vial 10 mL effective April 23, 2024, until May 15, 2024. During this time, our Ampicillin for Injection 500 mg SD Vial 10 mL will be available for substitution. Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Ampicillin for Injection 250 mg SD Vial 10 mL effective April 23, 2024, until May 7, 2024. During this time, our Ampicillin for Injection 500 mg SD Vial 10 mL will be available for substitution.
Health Canada comments